Provide expert opinion and analysis to commercial pharma clients. Areas of focus include forecasting, market research, incentive compensation, commercial strategy, commercial analytics, launch planning, business development opportunity analysis, and communications.

Created Commercial Operations and Analytics blueprint and built organization to support concurrent launches of a newly hired 300-person sales team and two products (Nexletol, Nexlizet) in March 2020. Recruited, hired, and led a team of eight professionals responsible for all forecasting, market research, commercial analysis and insights, sales operations, and competitive intel efforts.

Launched and led commercial operations activities for a new ~110-person commercial organization competing in the US cardiovascular market. Products included Toprol XL, Yosprala, and Zontivity. Reported to Chief Commercial Officer.- Recruited and led team responsible for all commercial operations functions including commercial strategy, analytics, sales operations, forecasting, market research, incentive comp, and competitive intelligence.- Member of cross-functional corporate development and licensing team; participated in commercial diligence associated with multiple acquisitions: Tribute Pharma, Zontivity, and Toprol XL. - Led pre-launch planning and research for two launches including price and access strategy, AMCP Dossier creation, KOL mapping, and brand positioning, messaging, and creative concepts.- Launched pharmacy initiative to secure alternative Rx distribution channels to navigate an evolving access and reimbursement environment.

Led all commercial analysis and operational support activities for ~400-person commercial organization competing in the men's health (Testim, Testopel, Striant, Stendra, Edex, Xiaflex), orthopedic (Xiaflex), and respiratory (Semprex-D, Theo-24) therapeutic categories.- Led a team of 18 in supporting four brand teams and four sales teams promoting 10 retail and “buy & bill” products. Managed $15M budget and led work activities in six core areas: forecasting; commercial analysis; sales operations; market research; incentive compensation; and competitive intelligence.- Reported to Chief Commercial Officer; served on Commercial Leadership Team responsible for establishing the strategic direction of the commercial organization.- Member of cross-functional development and licensing team; conducted commercial diligence associated with Actient Pharma acquisition and Stendra® (PED5i) licensing.- Led multiple commercial work streams associated with Endo acquisition and integration.

Provided expert opinion and analysis for commercial and business development clients in the pharmaceutical industry. - Assisted a public ex-US pharmaceutical company in assessing multiple company and product acquisitions, to support a potential US commercial presence. Deliverables included qual/quant market research and creation of demand forecasts and P&L models to support diligence and term sheet creation. Company launched US commercial organization in mid-2012.- Conducted a strategic, financial, and portfolio review of a public US biopharmaceutical company to assist client with evaluation of a potential CEO position.

Led commercial analysis and operational support efforts for ~130-person commercial team and business development team. Responsibilities include forecasting, licensing deal analysis, sales incentive compensation, market research, sales force automation, data management and reporting, commercial analysis, prescriber targeting, field sales alignments, sample accountability, sample and materials warehousing and distribution, and fleet.

Led Biovail’s managed care marketing efforts aimed at a targeted group of 375 U.S. PBMs and national managed care organizations. Responsible for developing marketing strategies, tactics, and materials used by Biovail’s managed care Account Executives to secure product formulary access and support pull-through activities for Cardizem-LA® and Teveten®. Developed the managed care marketing concept, created the tools and processes, and fostered the relationships to ensure pull-through success on managed care formulary wins.

Sold and led consulting engagements for industry-leading pharmaceutical companies. Created and presented business proposals, closed new business agreements, managed engagement team work activities and deliverables, and presented project findings and recommendations to clients.

Launched the ‘Process Support’ initiative and directed a team of internal consultants responsible for identifying and implementing process and technology improvements for the Mercedes-Benz U.S. automotive finance division.

Provided management consulting services to healthcare clients on financial, strategic and operational engagements. Managed projects up to $2.5 million in fees.